Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen M Coley

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2009
Overcoming multidrug resistance in cancer: clinical studies of p-glycoprotein inhibitorsHelen M Coley
Methods in Molecular Medicine|November 25, 2003
Development of drug-resistant modelsHelen M Coley
Cancer Treatment Reviews|March 28, 2008
Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancerHelen M Coley
Cancer Control : Journal of the Moffitt Cancer Center|April 25, 2003
Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoproteinHilary Thomas, Helen M Coley
Clinical Breast Cancer|November 21, 2007
The role of efflux pumps in drug-resistant metastatic breast cancer: new insights and treatment strategiesTito Fojo, Helen M Coley
Cancers|June 22, 2018
Crosstalk between ERα and Receptor Tyrosine Kinase Signalling and Implications for the Development of Anti-Endocrine ResistanceRugaia Z Montaser, Helen M Coley
Journal of Medicinal Chemistry|December 13, 2007
Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell linesHelen M Coley, Julien Sarju, Gabriele Wagner
Anticancer Research|March 14, 2007
Seliciclib (CYC202; r-roscovitine) in combination with cytotoxic agents in human uterine sarcoma cell linesHelen M Coley, Christine F Shotton, Hilary Thomas
Biochimica Et Biophysica Acta|March 17, 2006
Differences in the biophysical properties of membrane and cytoplasm of apoptotic cells revealed using dielectrophoresisFatima H Labeed, Helen M Coley, Michael P Hughes
Gynecologic Oncology|February 16, 2007
The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell linesHelen M Coley, Christine F Shotton, Maria I Kokkinos, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2009
Overcoming multidrug resistance in cancer: clinical studies of p-glycoprotein inhibitorsHelen M Coley
Methods in Molecular Medicine|November 25, 2003
Development of drug-resistant modelsHelen M Coley
Cancer Treatment Reviews|March 28, 2008
Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancerHelen M Coley
Cancer Control : Journal of the Moffitt Cancer Center|April 25, 2003
Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoproteinHilary Thomas, Helen M Coley
Clinical Breast Cancer|November 21, 2007
The role of efflux pumps in drug-resistant metastatic breast cancer: new insights and treatment strategiesTito Fojo, Helen M Coley
Cancers|June 22, 2018
Crosstalk between ERα and Receptor Tyrosine Kinase Signalling and Implications for the Development of Anti-Endocrine ResistanceRugaia Z Montaser, Helen M Coley
Journal of Medicinal Chemistry|December 13, 2007
Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell linesHelen M Coley, Julien Sarju, Gabriele Wagner
Anticancer Research|March 14, 2007
Seliciclib (CYC202; r-roscovitine) in combination with cytotoxic agents in human uterine sarcoma cell linesHelen M Coley, Christine F Shotton, Hilary Thomas
Biochimica Et Biophysica Acta|March 17, 2006
Differences in the biophysical properties of membrane and cytoplasm of apoptotic cells revealed using dielectrophoresisFatima H Labeed, Helen M Coley, Michael P Hughes
Gynecologic Oncology|February 16, 2007
The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell linesHelen M Coley, Christine F Shotton, Maria I Kokkinos, et al.
Pageof 4